Related Experiment Video
Updated: Nov 14, 2025
04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
5.9K
Targeting mesenchymal stem cell therapy for severe pneumonia patients
Guy Lam1, Yuan Zhou2, Jia-Xian Wang2
1School of Biomedical Sciences, University of Hong Kong, Hong Kong 999077, China.
World Journal of Stem Cells
|March 12, 2021
Summary
Mesenchymal stem cells show promise in treating severe pneumonia, including that caused by COVID-19. These stem cell therapies can reduce inflammation and improve immunity, offering a potential new treatment for lung inflammation.
Area of Science:
- Pulmonology
- Immunology
- Regenerative Medicine
Background:
- Pneumonia is a leading cause of death in children under 5.
- COVID-19 has caused significant mortality, often due to severe pneumonia and cytokine storm.
- There is a critical need for effective therapies beyond vaccines and drugs.
Purpose of the Study:
- To explore the potential of stem cell therapies for pneumonia.
- To evaluate mesenchymal stem cells (MSCs) as a treatment for COVID-19-associated pneumonia.
Main Methods:
- Review of basic research on stem cell capacities.
- Analysis of recent clinical trials involving MSCs for COVID-19 pneumonia.
Main Results:
- Stem cells can inhibit pneumonia-induced inflammation and pulmonary fibrosis.
- MSCs enhance antibacterial and antiviral immunity.
- Clinical trials indicate MSCs reduce morbidity and mortality in COVID-19 pneumonia.
Conclusions:
- Mesenchymal stem cells are effective in treating severe pneumonia.
- MSCs represent a promising next-generation therapy for lung inflammation and future health challenges.
Keywords:
Alveolar protectionClinical trialsHuman mesenchymal stem cellsImmunomodulationPandemic challengePneumoniaMore Related Videos
Related Concept Videos
01:19Mesenchymal Stem Cells
5.2K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
01:21Stem Cell Therapy for Tissue Regeneration
4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
01:28Pneumonia IV: Management
564
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
564